March 4, 2022 – Women who were younger at the time of their first menstrual period (menarche) are more likely to report chronic pain in adulthood, reports a study in PAIN®, the official publication of the International Association for the Study of Pain (IASP). The journal is published in the Lippincott portfolio by Wolters Kluwer.
“[W]e found strong associations between age at menarche and chronic pain outcomes in adult women,” according to the new research by Charlotte Indre Lund, PhD fellow in Epidemiology at Oslo University Hospital, and colleagues. The findings add to previous evidence suggesting that increased estrogen levels associated with early menarche may contribute to pain, and to sex differences in pain in general.
Early menarche linked to higher prevalence and longer duration of chronic pain
The study included data on more than 12,000 women (average age 55) participating in the Tromsø Study, an ongoing population study of the health of people in northern Norway. The researchers analyzed associations between women's self-reported age at menarche and the presence and characteristics of chronic pain. The women's reported average age at menarche was about 13 years. About 40% of women reported experiencing chronic pain.
Women with younger age at menarche were more likely to have chronic pain. After adjustment for potential confounding factors, the relative risk of chronic pain decreased by 2% for each one-year delay in menarche. Absolute risk decreased by 1.1 to 1.4 percentage points per year. Across the full range of reported ages – from 9 to 18 years – the absolute risk of chronic pain differed by 12.6 percentage points.
Older age at menarche was associated with lower rates of chronic pain in each of 10 body regions assessed, with the strongest associations for chest and abdominal pain. Younger age at menarche was associated with a longer duration of pain.
Based on recently updated criteria, the prevalence of chronic widespread pain (CWP) was 7.4%. Later menarche was associated with a decreased risk of experiencing CWP, with a risk ratio of 7% and absolute risk difference of 1.5 percentage points per year.
There are well-known sex differences in chronic pain conditions, with chronic pain rates higher in women compared to men. "The causes of sex differences in pain are poorly understood," Ms Lund and coauthors write. "However, one reason might be the different hormone exposure in the sexes throughout the lifetime." A few previous studies have found associations between early menarche and various pain diagnoses, including migraine and low back pain. They also cite previous studies reporting interactions between sex hormones and the immune system, and organizational effects of sex hormones on the nervous system during puberty.
Based on the new findings, the researchers conclude that "[A]ge at menarche is an independent risk factor for chronic pain, site-specific chronic pain, and chronic widespread pain and [thereby] contribute to the explanation of sex differences in pain,". Each additional year of delay to the first menstrual period is associated with a reduced risk for having chronic pain lasting 5 years or longer, as well as a reduced risk of CWP.
Note to media: The press contact for this study is senior researcher Christopher Sivert Nielsen, PhD (firstname.lastname@example.org)
PAIN is IASP's official journal. Published monthly, PAIN presents original research on the nature, mechanisms, and treatment of pain. Available to IASP members as a membership benefit, this peer-reviewed journal provides a forum for the dissemination of multidisciplinary research in the basic and clinical sciences. It is cited in Current Contents and Index Medicus.
About the International Association for the Study of Pain
IASP is the leading professional organization for science, practice, and education in the field of pain. Membership is open to all professionals involved in research, diagnosis, or treatment of pain. IASP has more than 7,000 members in 133 countries, 90 national chapters, and 20 special interest groups (SIGs). IASP brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain and translate that knowledge into improved pain relief worldwide.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.